Has Kelli Mills received payments from drug or device companies?

Yes. Drug and device makers reported $5,016 in general payments to Kelli Mills across 262 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kelli Mills did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kelli Mills come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kelli Mills

Psychiatric/Mental Health · London, KYNPI 1235622390

Payments from drug & device makers

$5,016in general payments, 2019–2025

Across 262 payments — averaging $19.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$884
Otsuka America Pharmaceutical, Inc.$794
Vanda Pharmaceuticals Inc.$566
Johnson & Johnson$540
Alkermes, Inc.$422
E.r. Squibb & Sons, L.L.C.$247
plus $2K from 13 others

What the payments were for

Food & beverage$4,96999%
Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	41	$884
Otsuka America Pharmaceutical, Inc.	47	$794
Vanda Pharmaceuticals Inc.	29	$566
Johnson & Johnson	16	$540
Alkermes, Inc.	34	$422
E.r. Squibb & Sons, L.L.C.	8	$247
Lundbeck LLC	16	$243
Axsome Therapeutics, Inc.	11	$223
Ironshore Pharmaceuticals Inc.	13	$219
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	10	$201
Takeda Pharmaceuticals U.S.A., Inc.	9	$127
Almatica Pharma LLC	4	$100
Teva Pharmaceuticals USA, Inc.	5	$93
Biogen	4	$87
Supernus Pharmaceuticals, Inc.	5	$79
Indivior Inc.	2	$73
Idorsia Pharmaceuticals US Inc	4	$57
Neurocrine Biosciences, Inc.	3	$44
Avanir Pharmaceuticals, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,016 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	14	$43,356
CaplytaLumateperone Tosylate	13	$21,254
RexultiBrexpiprazole	12	$17,299
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	77	$7,438
Citalopram HbrCitalopram Hydrobromide	14	$1,378
Aripiprazole	26	$1,375
Quetiapine Fumarate	98	$1,036
Duloxetine Hcl	50	$709
Fluoxetine Hcl	84	$698
Buspirone Hcl	59	$519
Amitriptyline Hcl	42	$321
Clonazepam	55	$168
Propranolol Hcl	19	$163
Sertraline Hcl	56	$139
Trazodone Hcl	44	$136

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna	$540	$43,35614 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$201	$21,25413 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$794	$17,29912 claims
Almatica Pharma LLCSertraline Hcl	$100	$13956 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in London

Tammy WhiteheadLondon$19K
Jerry KunkelLondon$13K
Theresa WattsAshland$645K
Rachel ColeHopkinsville$503K
Denise de AngelisLouisville$384K
Jennifer SampangCrestview Hills$322K
Jeremy FisherSouth Shore$197K
Jessica EstesLewisport$175K
Christopher MulloneyNancy$95K
Davika MattoxMorehead$79K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →